MedPath

润尔眼科药物(广州)有限公司

Ownership
-
Established
2020-08-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20244698
Approval Date
Aug 20, 2024
NMPA

Bromfenac Sodium Eye Drops

Product Name
溴芬酸钠滴眼液
Approval Number
国药准字H20244161
Approval Date
Jun 25, 2024
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath